Total raised
$625.0M
Last stage
Series F
Investors
Nathaniel Fernhoff
PhD in molecular and cell biology from UC Berkeley; former postdoctoral scholar in Irving Weissman's lab at Stanford. Inventor of Orca-Q cell therapy. Appointed CEO in May 2025, having previously served as Chief Scientific Officer.
Ivan Dimov
PhD in applied biophysics from Dublin City University. Former Senior Scientist at Stanford University. Also co-founder and former CTO of Lucira Health. Led Orca Bio as CEO from founding until 2025.
LinkedInJeroen Bekaert
PhD in computer science engineering from Ghent University; MBA from Stanford GSB. Previously head of Merck KGaA's innovation center in Silicon Valley, and Director at Johnson & Johnson's Supply Chain group. Started career as researcher at Los Alamos National Laboratory.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.